Search research articles
Contact Us
Filters
Showing results (61-70 of 128) with videos related to
Page
of 13
Sort By:
Gastroenterology
|
November 15, 2020
Association Between Preadmission Acid Suppressive Medication Exposure and Severity of Illness in Patients Hospitalized With COVID-19
B Joseph Elmunzer, Bethany J Wolf, James M Scheiman, et al.
The American Journal of Gastroenterology
|
June 20, 2020
Clinical and Economic Outcomes of Patients Undergoing Guideline-Directed Management of Pancreatic Cysts
Jennifer M Lobo, James M Scheiman, Victor M Zaydfudim, et al.
International Journal of Cardiology
|
January 26, 2015
Effect of esomeprazole on gastroduodenal erosions in patients at increased gastrointestinal risk treated with low-dose acetylsalicylic acid: a post-hoc analysis of the OBERON trial
James M Scheiman, Angel Lanas, Sander Veldhuyzen van Zanten, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 7, 2004
A randomized, controlled comparison of ibuprofen at the maximal over-the-counter dose compared with prescription-dose celecoxib on upper gastrointestinal mucosal injury
James M Scheiman, Byron Cryer, Michael B Kimmey, et al.
Academic Radiology
|
June 18, 2003
Making cost-effectiveness analyses clinically relevant: the effect of provider expertise and biliary disease prevalence on the economic comparison of alternative diagnostic strategies
Ruth C Carlos, James M Scheiman, Hero K Hussain, et al.
Arthritis Research & Therapy
|
March 30, 2007
Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies
Christopher J Hawkey, Nicholas J Talley, James M Scheiman, et al.
Journal of Clinical Gastroenterology
|
February 19, 2003
Intrasphincteric botulinum toxin versus pneumatic balloon dilation for treatment of primary achalasia
Rajiv Bansal, Timothy T Nostrant, James M Scheiman, et al.
Cardiovascular Therapeutics
|
January 5, 2016
Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI Risk
Jay L Goldstein, David J Whellan, James M Scheiman, et al.
Gastrointestinal Endoscopy
|
May 29, 2013
A survey of expert follow-up practices after successful endoscopic eradication therapy for Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma
Aarti O Bedi, Richard S Kwon, Joel H Rubenstein, et al.
The American Journal of Gastroenterology
|
April 22, 2005
Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors
Chris Hawkey, Nicholas J Talley, Neville D Yeomans, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 128) with videos related to
Sort By:
Page
of 13
Gastroenterology
|
November 15, 2020
Association Between Preadmission Acid Suppressive Medication Exposure and Severity of Illness in Patients Hospitalized With COVID-19
B Joseph Elmunzer, Bethany J Wolf, James M Scheiman, et al.
The American Journal of Gastroenterology
|
June 20, 2020
Clinical and Economic Outcomes of Patients Undergoing Guideline-Directed Management of Pancreatic Cysts
Jennifer M Lobo, James M Scheiman, Victor M Zaydfudim, et al.
International Journal of Cardiology
|
January 26, 2015
Effect of esomeprazole on gastroduodenal erosions in patients at increased gastrointestinal risk treated with low-dose acetylsalicylic acid: a post-hoc analysis of the OBERON trial
James M Scheiman, Angel Lanas, Sander Veldhuyzen van Zanten, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 7, 2004
A randomized, controlled comparison of ibuprofen at the maximal over-the-counter dose compared with prescription-dose celecoxib on upper gastrointestinal mucosal injury
James M Scheiman, Byron Cryer, Michael B Kimmey, et al.
Academic Radiology
|
June 18, 2003
Making cost-effectiveness analyses clinically relevant: the effect of provider expertise and biliary disease prevalence on the economic comparison of alternative diagnostic strategies
Ruth C Carlos, James M Scheiman, Hero K Hussain, et al.
Arthritis Research & Therapy
|
March 30, 2007
Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies
Christopher J Hawkey, Nicholas J Talley, James M Scheiman, et al.
Journal of Clinical Gastroenterology
|
February 19, 2003
Intrasphincteric botulinum toxin versus pneumatic balloon dilation for treatment of primary achalasia
Rajiv Bansal, Timothy T Nostrant, James M Scheiman, et al.
Cardiovascular Therapeutics
|
January 5, 2016
Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI Risk
Jay L Goldstein, David J Whellan, James M Scheiman, et al.
Gastrointestinal Endoscopy
|
May 29, 2013
A survey of expert follow-up practices after successful endoscopic eradication therapy for Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma
Aarti O Bedi, Richard S Kwon, Joel H Rubenstein, et al.
The American Journal of Gastroenterology
|
April 22, 2005
Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors
Chris Hawkey, Nicholas J Talley, Neville D Yeomans, et al.
Page
of 13